Elizabeth Hagen, MD Pediatrics Medicare: Medicare Enrolled Practice Location: N143w6515 Pioneer Rd, Cedarburg, WI 53012 Phone: 262-377-6933 |
Dr. Matthew Maves, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 7861 State Road 60, Cedarburg, WI 53012 Phone: 262-546-1050 Fax: 262-546-1051 |
Carol J Estill, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7861 State Road 60, Cedarburg, WI 53012 Phone: 262-546-1050 Fax: 262-546-1051 |
Dr. Lori Ann Albright, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 7861 State Road 60, Cedarburg, WI 53012 Phone: 262-546-1050 Fax: 262-546-1051 |
Boyd Miller, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7861 State Road 60, Cedarburg, WI 53012 Phone: 262-546-1050 Fax: 262-546-1051 |
Elizabeth Ann Doro, MSN, RN, CPNP-AC Pediatrics Medicare: Medicare Enrolled Practice Location: 7861 State Road 60, Cedarburg, WI 53012 Phone: 262-546-1050 Fax: 262-546-1051 |
Daniel A Hagerman, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: N143w6515 Pioneer Rd, Cedarburg, WI 53012 Phone: 262-377-6399 |
Edwin Montgomery, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: N143w6515 Pioneer Rd, Cedarburg, WI 53012 Phone: 262-377-6933 |
News Archive
Eli Lilly and Company today commented on a ruling issued by the U.S. District Court for the Southern District of California granting a request by Amylin Pharmaceuticals for a temporary restraining order (TRO) related to litigation involving the two companies' diabetes collaboration agreement.
Psychosis, mania, and depression are unlikely to have shared hereditary causes, report researchers in Molecular Psychiatry.
While millions of viewers around the world are watching breathtaking ski jumps, razor-sharp skating moves and other awe-inspiring athletic feats in Vancouver over the next few weeks, the official doping control laboratory of the 2010 Winter Games will be casting an equally intent eye on the athletes who are competing.
AB Science SA, a pharmaceutical company specialising in the research, development and commercialisation of protein kinase inhibitors (PKIs), announced today the recruitment of the first patient in the phase 3 study evaluating masitinib in severe persistent asthma.
› Verified 7 days ago